Nonpeptide αvβ3 antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide
- 7 January 2002
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (1) , 25-29
- https://doi.org/10.1016/s0960-894x(01)00687-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Antagonism of the Osteoclast Vitronectin Receptor with an Orally Active Nonpeptide Inhibitor Prevents Cancellous Bone Loss in the Ovariectomized RatJournal of Bone and Mineral Research, 2001
- Nonpeptide αvβ3 Antagonists. 1. Transformation of a Potent, Integrin-Selective αIIbβ3 Antagonist into a Potent αvβ3 AntagonistJournal of Medicinal Chemistry, 2000
- Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp MimeticJournal of Medicinal Chemistry, 1999
- The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and RatsEndocrinology, 1998
- A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.Journal of Clinical Investigation, 1997
- Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized ratEndocrinology, 1996
- Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing proteinEndocrinology, 1993
- Platelet Membrane Glycoprotein IIb/IIIa: Member of a Family of Arg-Gly-Asp—Specific Adhesion ReceptorsScience, 1986
- A simple preparation of a .beta.-iodo acetal and a .beta.-iodo ketalThe Journal of Organic Chemistry, 1983
- Regiospecific electrophilic substitution of aminopyridines: ortho lithiation of 2-, 3-, and 4-(pivaloylamino)pyridinesThe Journal of Organic Chemistry, 1983